Seekyo's strategy includes a highly selective mechanism of drug release based on enzymatic activation, avoiding early or uncontrolled release responsible for the adverse effects...
By developing a Tumor Activated Therapy TM, we aim at a high selectivity in the treatment, boosting efficacy while reducing adverse effects...
The next generation of targeted therapy for solid cancer